共 3 条
[2]
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2006, 47 (10)
:1997-2004